Crossmark

CSR, firm financial performance and corporate life cycle: empirical evidence from china’s pharmaceutical industry

Crossref DOI link: https://doi.org/10.1007/s11156-026-01489-7

Published Online: 2026-02-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Claire

Mathew, Sudha https://orcid.org/0000-0002-5196-4761
Malki, Issam

Benamraoui, Abdelhafid

Shah, Neeta
License Information

Text and Data Mining valid from 2026-02-20

Version of Record valid from 2026-02-20
More Information

Article History

Received: 26 February 2024

Accepted: 16 December 2025

First Online: 20 February 2026